Your search returned 2 results.

Results
	1.	SPRY2 is an inhibitor of the ras/extracellular signal-regulated kinase pathway in melanocytes and melanoma cells with wild-type BRAF but not with the V599E mutant. [electronic resource] by Tsavachidou, Dimitra Coleman, Mathew L Athanasiadis, Galene Li, Shuixing Licht, Jonathan D Olson, Michael F Weber, Barbara L Producer: 20040930 In: Cancer research vol. 64 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Interleukin-6 -174G-->C polymorphism is associated with improved outcome in high-risk breast cancer. [electronic resource] by DeMichele, Angela Martin, Anne-Marie Mick, Rosemarie Gor, Priya Wray, Lisa Klein-Cabral, Melissa Athanasiadis, Galene Colligan, Theresa Stadtmauer, Edward Weber, Barbara Producer: 20040209 In: Cancer research vol. 63 Availability: No items available. Save to lists Add to cart (remove)

Refine your search